BRIEF-FDA approves GlaxoSmithKline's four-strain flu vaccine

LONDON Mon Dec 17, 2012 10:15am EST

Related Topics

LONDON Dec 17 (Reuters) - GlaxoSmithKline Plc : * Announced today that the U.S. food and drug administration (FDA) has approved

fluarix quadrivalent * Will make fluarix quadrivalent available in time for the 2013-14 flu season

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.